Ascendis Pharma's total assets for Q4 2024 were €1.18B, an increase of 55.55% from the previous quarter. ASND total liabilities were €1.29B for the fiscal quarter, a 19.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.